4,697 Shares in Synopsys, Inc. $SNPS Bought by Sumitomo Life Insurance Co.

Sumitomo Life Insurance Co. acquired a new position in Synopsys, Inc. (NASDAQ:SNPS) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 4,697 shares of the semiconductor company’s stock, valued at approximately $2,095,000.

A number of other institutional investors also recently bought and sold shares of the stock. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in Synopsys during the second quarter valued at $747,400,000. China Universal Asset Management Co. Ltd. grew its position in shares of Synopsys by 31.8% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 14,810 shares of the semiconductor company’s stock worth $6,957,000 after buying an additional 3,575 shares during the period. Norges Bank bought a new position in shares of Synopsys in the 4th quarter worth about $730,197,000. SBI Okasan Asset Management Co.Ltd. bought a new position in shares of Synopsys in the 4th quarter worth about $1,699,000. Finally, Atreides Management LP purchased a new position in Synopsys during the 1st quarter valued at about $54,288,000. 85.47% of the stock is owned by institutional investors.

Synopsys Stock Down 0.0%

Shares of Synopsys stock opened at $397.87 on Friday. Synopsys, Inc. has a twelve month low of $366.00 and a twelve month high of $615.79. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The company’s 50 day moving average is $419.73 and its 200 day moving average is $440.22. The company has a market cap of $76.18 billion, a price-to-earnings ratio of 92.10, a price-to-earnings-growth ratio of 2.34 and a beta of 1.23.

Synopsys (NASDAQ:SNPS) last posted its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion during the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The firm’s revenue was up 41.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Research analysts anticipate that Synopsys, Inc. will post 10.65 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Stifel Nicolaus boosted their price objective on shares of Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Citigroup raised their target price on shares of Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Berenberg Bank set a $633.00 price target on Synopsys in a research report on Wednesday, May 27th. Zacks Research upgraded Synopsys from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, June 30th. Finally, Wells Fargo & Company reduced their price objective on Synopsys from $535.00 to $450.00 and set an “equal weight” rating for the company in a research report on Tuesday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Synopsys currently has a consensus rating of “Moderate Buy” and an average target price of $563.59.

Insiders Place Their Bets

In related news, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.56% of the company’s stock.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.